Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-23 Other | 2023-03-27 4:09 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Hwang Kuk Hyoun Chief Executive Officer 10% Owner | 20,000 | $0 | 2,390,500 (Indirect) | View |
| 2023-03-23 Option Award | 2023-03-27 4:06 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Yoo David Jin Chief Financial Officer | 20,000 | $0 | 40,000 (Direct) | View |
| 2023-03-23 Other | 2023-03-27 4:03 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Bellevue Global Life Science Investors LLC 10% Owner | 20,000 | $0 | 2,390,500 (Direct) | View |
| 2023-02-21 Other | 2023-02-23 4:31 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Hwang Kuk Hyoun Chief Executive Officer 10% Owner | 229,500 | $0 | 2,250,000 (Indirect) | View |
| 2023-02-21 Other | 2023-02-23 4:30 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Bellevue Global Life Science Investors LLC 10% Owner | 229,500 | $0 | 2,250,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 8:05 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | REED STEVEN Director | 20,000 | $0 | 40,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 8:02 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Chung In Chul Director | 20,000 | $0 | 40,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 8:00 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Roberts Rad Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 7:59 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Park Jin Whan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 7:53 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Euh Hosun Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-14 Other | 2023-02-16 7:52 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Bellevue Global Life Science Investors LLC 10% Owner | 295,000 | $0 | 3,385,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 7:52 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Bellevue Global Life Science Investors LLC 10% Owner | 430,000 | $10 | 3,385,000 (Direct) | View |
| 2023-02-14 Other | 2023-02-16 7:51 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Hwang Kuk Hyoun Chief Executive Officer 10% Owner | 295,000 | $0 | 3,385,000 (Indirect) | View |
| 2023-02-14 Option Award | 2023-02-16 7:51 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Hwang Kuk Hyoun Chief Executive Officer 10% Owner | 430,000 | $10 | 3,385,000 (Indirect) | View |
Ownership | 2023-02-09 4:51 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Yoo David Jin Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
Ownership | 2023-02-09 4:49 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Bellevue Global Life Science Investors LLC 10% Owner | 0 | $0 | 1,725,000 (Direct) | View |
Ownership | 2023-02-09 4:46 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Whang Jun Chul Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2023-02-09 4:45 pm | N/A N/A | Bellevue Life Sciences Acquisition Corp. | BLAC | Hwang Kuk Hyoun See Remarks 10% Owner | 0 | $0 | 1,725,000 (Indirect) | View |